Evidence-Based Medicine Guidelines
Eslicarbazepine add-on for drug-resistant partial epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Eslicarbazepine Add-on for Drug-resistant Partial Epilepsy." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457421/all/Eslicarbazepine_add_on_for_drug_resistant_partial_epilepsy.
Eslicarbazepine add-on for drug-resistant partial epilepsy. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457421/all/Eslicarbazepine_add_on_for_drug_resistant_partial_epilepsy. Accessed October 9, 2024.
Eslicarbazepine add-on for drug-resistant partial epilepsy. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457421/all/Eslicarbazepine_add_on_for_drug_resistant_partial_epilepsy
Eslicarbazepine Add-on for Drug-resistant Partial Epilepsy [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457421/all/Eslicarbazepine_add_on_for_drug_resistant_partial_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Eslicarbazepine add-on for drug-resistant partial epilepsy
ID - 457421
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457421/all/Eslicarbazepine_add_on_for_drug_resistant_partial_epilepsy
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
